Floatz logo

Folic Acid

Refractory Peripheral T-Cell Lymphoma

Acrotech Biopharma Inc.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Refractory Peripheral T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Cobalamin
Acrotech Biopharma Inc.
Phase 2B
Olaparib
National Cancer Centre, Singapore
Phase 2CCC

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →